title: Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.
abstract: There is no consensus regarding how to manage osteonecrosis in pediatric acute lymphoblastic leukemia patients. Therefore, we performed a quality assessment of the literature with the result of a search strategy using the MESH terms osteonecrosis, children, childhood cancer, surgery, bisphosphonates, 6 hydroxymethyl-glutaryl CoA reductase inhibitors, anticoagulants and hyperbaric oxygen, and terms related to these MESH terms. A randomized controlled trial showed that osteonecrosis can be prevented by intermittent, instead of continuous, corticosteroid administration. The studies on interventions after onset of osteonecrosis were of low-quality evidence. Seven pediatric acute lymphoblastic leukemia studies described non-surgical interventions; bisphosphonates (n=5), hyperbaric oxygen therapy (n=1), or prostacyclin analogs (n=1). Safety and efficacy studies are lacking. Five studies focused on surgical interventions; none was of sufficient quality to draw definite conclusions. In conclusion, preventing osteonecrosis is feasible in a proportion of the pediatric acute lymphoblastic leukemia patients by discontinuous, instead of continuous, steroid scheduling. The questions as to how to treat childhood acute lymphoblastic leukemia patients with osteonecrosis cannot be answered as good-quality studies are lacking.
authors.affiliation: m.vandenheuvel@erasmusmc.nl.
authors.forename: Mariël L
authors.initials: ML
authors.lastname: Te Winkel
authors.forename: Rob
authors.initials: R
authors.lastname: Pieters
authors.forename: Ernst-Jan D
authors.initials: EJ
authors.lastname: Wind
authors.forename: J H J M Gert
authors.initials: JH
authors.lastname: Bessems
authors.forename: Marry M
authors.initials: MM
authors.lastname: van den Heuvel-Eibrink
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D019468:Disease Management; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010020:Osteonecrosis / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy